200 related articles for article (PubMed ID: 35580331)
1. Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.
Jana AK; Lander CW; Chesney AD; Hansmann UHE
J Phys Chem B; 2022 May; 126(20):3648-3658. PubMed ID: 35580331
[TBL] [Abstract][Full Text] [Related]
2. Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils.
Jana AK; Lander CW; Chesney AD; Hansmann UHE
bioRxiv; 2022 Feb; ():. PubMed ID: 35233574
[TBL] [Abstract][Full Text] [Related]
3. SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein.
Chesney AD; Maiti B; Hansmann UHE
J Chem Phys; 2023 Jul; 159(1):. PubMed ID: 37409768
[TBL] [Abstract][Full Text] [Related]
4. Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently.
Mesias VSD; Zhu H; Tang X; Dai X; Liu W; Guo Y; Huang J
J Phys Chem Lett; 2022 Nov; 13(45):10642-10648. PubMed ID: 36354180
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 N-protein induces the formation of composite α-synuclein/N-protein fibrils that transform into a strain of α-synuclein fibrils.
Semerdzhiev SA; Segers-Nolten I; van der Schoot P; Blum C; Claessens MMAE
Nanoscale; 2023 Nov; 15(45):18337-18346. PubMed ID: 37921451
[TBL] [Abstract][Full Text] [Related]
6. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein.
Semenyuk PI
Biophys Chem; 2024 Apr; 307():107196. PubMed ID: 38335809
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.
Zilio G; Masato A; Sandre M; Caregnato A; Moret F; Maciola AK; Antonini A; Brucale M; Cendron L; Plotegher N; Bubacco L
ACS Chem Neurosci; 2024 Jan; 15(2):215-221. PubMed ID: 38131609
[TBL] [Abstract][Full Text] [Related]
9. SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein.
Chesney AD; Maiti B; Hansmann UHE
bioRxiv; 2023 May; ():. PubMed ID: 37214999
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
Werner T; Horvath I; Wittung-Stafshede P
J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
[TBL] [Abstract][Full Text] [Related]
11. Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation.
Semerdzhiev SA; Fakhree MAA; Segers-Nolten I; Blum C; Claessens MMAE
ACS Chem Neurosci; 2022 Jan; 13(1):143-150. PubMed ID: 34860005
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
Watson MD; Lee JC
Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
[TBL] [Abstract][Full Text] [Related]
13. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
Tavassoly O; Yue J; Vocadlo DJ
FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
[TBL] [Abstract][Full Text] [Related]
15. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
Rekas A; Ahn KJ; Kim J; Carver JA
Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
[TBL] [Abstract][Full Text] [Related]
16. Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein.
Devi S; Garg DK; Bhat R
Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140917. PubMed ID: 37061153
[TBL] [Abstract][Full Text] [Related]
17. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L
PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053
[TBL] [Abstract][Full Text] [Related]
18. Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A.
Jana AK; Greenwood AB; Hansmann UHE
J Phys Chem B; 2021 Aug; 125(32):9155-9167. PubMed ID: 34370466
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of the Relative Fragmentation Stabilities of Polymorphic Alpha-Synuclein Amyloid Fibrils.
Sanami S; Purton TJ; Smith DP; Tuite MF; Xue WF
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625557
[TBL] [Abstract][Full Text] [Related]
20. A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.
Moriarty GM; Olson MP; Atieh TB; Janowska MK; Khare SD; Baum J
J Biol Chem; 2017 Sep; 292(39):16368-16379. PubMed ID: 28710275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
